Document is current
Any future updates will be listed below
-
Authors
Lafont, Elodie
Kantari‐Mimoun, Chahrazade
Draber, Peter
De Miguel, Diego
Hartwig, Torsten
Reichert, Matthias
Kupka, Sebastian
Shimizu, Yutaka
Taraborrelli, Lucia
Spit, Maureen
Sprick, Martin R
Walczak, Henning https://orcid.org/0000-0002-6312-4591
-
Funding
Funding for this research was provided by:
Wellcome (096831/Z/11/Z)
European Research Council (294880)
Cancer Research UK (A17341)
Cancer Research UK (515818)
Cancer Research UK (525877)
Biotechnology and Biological Sciences Research Council (BB/J013129/1)
KWF Kankerbestrijding (BUIT 2015‐7526)
- License Information
-
More Information
Article History
Received: 20 September 2016
Revised: 30 January 2017
Accepted: 13 February 2017
First Online: 3 March 2017
Conflict of interest
: H.W. is co‐founder and shareholder of Apogenix AG. Otherwise the authors declare that they have no conflict of interest.
